Microfluidic Applications in Prostate Cancer Research.
Kailie Szewczyk1, Linan Jiang1, Hunain Khawaja2
1Department of Aerospace and Mechanical Engineering, University of Arizona, Tucson, AZ 85721, USA.
Micromachines
|October 26, 2024
Summary
Microfluidic organ-on-chip technology offers a new way to study prostate cancer, improving on traditional models. This approach aids in understanding and potentially treating advanced prostate cancer.
Area of Science:
- Oncology
- Biotechnology
- Bioengineering
Background:
- Prostate cancer is a leading cause of cancer death in men, often due to metastasis.
- Traditional cell cultures and animal models have limitations in predicting human physiological responses.
- Microfluidics offers advanced in vitro models that better mimic in vivo microenvironments.
Purpose of the Study:
- To review recent microfluidic applications in prostate cancer research.
- To highlight microfluidics' role in modeling prostate cancer initiation, development, detection, and therapy.
- To discuss the potential of microfluidics in overcoming challenges in treating metastatic castration-resistant prostate cancer.
Main Methods:
- Review of existing literature on microfluidic systems for prostate cancer research.
- Analysis of organ-on-chip and other microphysiological systems.
- Discussion of technological advancements and their application to prostate cancer.
Main Results:
- Microfluidic systems, including organ-on-chips, can effectively model human prostate tissue and disease progression.
- These systems provide superior microenvironments compared to traditional models.
- Microfluidics shows promise in advancing prostate cancer detection and therapeutic strategies.
Conclusions:
- Microfluidics represents a paradigm shift in life sciences, particularly for cancer research.
- Organ-on-chip technology bridges the gap between traditional models and in vivo studies.
- Microfluidic applications hold significant potential for the future eradication of prostate cancer.
